KDR and cancer: Surprisingly, sunitinib was also shown to upregulate EMT in cancer cells, thereby illustrating that although VEGFR-targeting antiangiogenic agents play an essential role in the therapy of some human malignancies, they may promote disease progression by stimulation of invasion and metastasis of cancer cells.